These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 3768069)

  • 1. Inhibition of thromboxane synthetase by the imidazole derivative 3-(1H-imidazol-1-yl-methyl)-2-methyl-1H-indole-1-propanoic acid as a novel therapeutic approach to experimental myocardial ischemia.
    Korb H; Hoeft A; Wober W; Wolpers HG; Hellige G
    Arzneimittelforschung; 1986 Jul; 36(7):1040-4. PubMed ID: 3768069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interference with the prostaglandin system as a therapeutical concept to protect the myocardium during ischemic stress: experimental studies with inhibition of thromboxane synthesis.
    Korb H; Hoeft A; Borowski A; de Vivie ER; Hellige G
    Thorac Cardiovasc Surg; 1988 Aug; 36(4):187-93. PubMed ID: 3187978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preservation of myocardium in transient ischemia by the thromboxane synthetase inhibitor UK 38.485.
    Hoeft A; Korb H; Böck J; Wolpers HG; Wober W; Hellige G
    Res Exp Med (Berl); 1986; 186(1):35-46. PubMed ID: 3961276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of the metabolic and energetic situation of ischemically stressed myocardium by verapamil after experimental coronary artery occlusion.
    Korb H; Hoeft A; Baller D; Schräder R; Wolpers HG; Hellige G
    Arzneimittelforschung; 1983; 33(11):1546-51. PubMed ID: 6686450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of dichloroacetate in the ischemic heart. Analysis of hemodynamics, myocardial energy metabolism and myocardial pH].
    Mizushima M
    Hokkaido Igaku Zasshi; 1990 May; 65(3):298-310. PubMed ID: 2379912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a novel thromboxane A2 synthetase inhibitor on ischemia-induced mitochondrial dysfunction in canine hearts.
    Ogawa T; Hieda N; Sugiyama S; Toki Y; Ito T; Ogawa K; Satake T; Ozawa T
    Arzneimittelforschung; 1988 Feb; 38(2):228-30. PubMed ID: 3370069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of nicorandil in the preservation of myocardium stressed by transient ischemia and its influence on cardiac metabolism during coronary artery occlusion with subsequent reperfusion: a comparison with isosorbide dinitrate.
    Korb H; Hoeft A; Hunneman DH; Schraeder R; Wolpers HG; Hellige G
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun; 329(4):440-6. PubMed ID: 3162106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a N(6)-disubstituted adenosine derivative on myocardial metabolism and ischemic stress following coronary occlusion.
    Kahles H; Junggeburth J; Lick T; Schäfer W; Kochsiek K
    Arzneimittelforschung; 1987 Oct; 37(10):1137-40. PubMed ID: 3435585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved lactate extraction in dogs with coronary artery ligation following administration of a thromboxane synthetase inhibitor.
    Eddy LJ; Oei HH; Glenn TM
    Res Commun Chem Pathol Pharmacol; 1983 Jan; 39(1):87-97. PubMed ID: 6682567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in myocardial substrate utilisation and protection of ischemic stressed myocardium by oxfenicine [(S)-4-hydroxyphenylglycine].
    Korb H; Hoeft A; Hunneman DH; Schraeder R; Wolpers HG; Wober W; Hellige G
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):70-4. PubMed ID: 6493353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial salvage by a novel thromboxane A2 synthetase inhibitor in a canine coronary occlusion-reperfusion model.
    Toki Y; Hieda N; Okumura K; Hashimoto H; Ito T; Ogawa K; Satake T
    Arzneimittelforschung; 1988 Feb; 38(2):224-7. PubMed ID: 3370068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac performance during reperfusion improved by pretreatment with oxygen free-radical scavengers.
    Otani H; Engelman RM; Rousou JA; Breyer RH; Lemeshow S; Das DK
    J Thorac Cardiovasc Surg; 1986 Feb; 91(2):290-5. PubMed ID: 3945096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of nitroglycerin on myocardial function in short-term ischemia].
    Moskvitina OA; Trubetskoĭ AV
    Biull Eksp Biol Med; 1982 Jul; 94(7):13-5. PubMed ID: 6812664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoactive parathyroid hormone in the treatment of acute ischemic left ventricular failure and the prevention of cardiogenic shock.
    Feola M; Gonzales H; Canizaro PC
    Circ Shock; 1985; 17(2):163-77. PubMed ID: 4053300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of delayed preconditioning on myocardial regional contractility during repeated episodes of low-flow ischaemia in anaesthetized dogs: possible role of nitric oxide.
    Szigeti Z; Simon K; Parratt JR; Végh A
    Clin Sci (Lond); 2004 Feb; 106(2):201-13. PubMed ID: 14556644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative effects of nitroglycerin and nitroprusside during experimental acute myocardial ischemia.
    Pearlman AS; Engler RL; Goldstein RA; Kent KM; Epstein SE
    Eur J Cardiol; 1980; 11(4):295-313. PubMed ID: 6771145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of catecholamine effects on canine myocardial metabolism and regional blood flow during and after cardiopulmonary bypass.
    Ward HB; Einzig S; Wang T; Bianco RW; Foker JE
    J Thorac Cardiovasc Surg; 1984 Mar; 87(3):452-65. PubMed ID: 6700252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A canine model of acute coronary artery stenosis: effects of deliberate hypotension.
    Hickey RF; Verrier ED; Baer RW; Vlahakes GJ; Fein G; Hoffman JI
    Anesthesiology; 1983 Sep; 59(3):226-36. PubMed ID: 6881588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a thromboxane synthetase inhibitor in circumflex coronary artery occlusion and reperfusion.
    Huddleston CB; Lupinetti FM; Clanton J; Collins J; Oates JA; Hammon JW
    Curr Surg; 1983; 40(3):211-5. PubMed ID: 6683615
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction.
    Smits GJ; McVey M; Cox BF; Perrone MH; Clark KL
    J Pharmacol Exp Ther; 1998 Aug; 286(2):611-8. PubMed ID: 9694911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.